Predictive value of T cell receptor repertoire profiling for immunosuppressive therapy in severe aplastic anemia

Cunte Chen; Yuling Zhang; Dongpei Lu; Zelong Zhang; Jun Yang; Xiaowei Chen; Ming Zhou; Wenjian Mo; Caixia Wang; Qinghua Cai; Yumiao Li; Ruiqing Zhou; Shilin Xu; Wei Zhou; Tingfen Deng; Shiyi Pan; Yanli Xu; Shunqing Wang; Yuping Zhang

doi:10.1016/j.gendis.2023.03.027

您当前的位置：

首页 >

文章列表页 >

Predictive value of T cell receptor repertoire profiling for immunosuppressive therapy in severe aplastic anemia

Short communication | 更新时间：2024-02-04

- Predictive value of T cell receptor repertoire profiling for immunosuppressive therapy in severe aplastic anemia
- Genes & Diseases Vol. 1, Issue 1, Pages: 95-98(2024)
- 作者机构：
  
  1. Department of Hematology, Guangzhou First People's Hospital, South China University of Technology,Guangdong,Guangzhou,China,510180
  2. Guangzhou Junruikang Biotechnology Co., Ltd,Guangdong,Guangzhou,China,510700
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2023.03.027
  CLC：
- Published：2024，
  
  Published Online：1 January 2024，
扫描看全文
Cunte Chen, Yuling Zhang, Dongpei Lu, et al. Predictive value of T cell receptor repertoire profiling for immunosuppressive therapy in severe aplastic anemia. [J]. Genes & Diseases 1(1):95-98(2024)
DOI：

Cunte Chen, Yuling Zhang, Dongpei Lu, et al. Predictive value of T cell receptor repertoire profiling for immunosuppressive therapy in severe aplastic anemia. [J]. Genes & Diseases 1(1):95-98(2024) DOI： 10.1016/j.gendis.2023.03.027.

摘要

Abstract

关键词

Keywords

references

1 V. Giudice, X. Feng, Z. Lin, et al.Deep sequencing and flow cytometric characterization of expanded effector memory CD8+ CD57+ T cells frequently reveals T-cell receptor Vβ oligoclonality and CDR3 homology in acquired aplastic anemia Haematologica, 103 (5) (2018), pp. 759-769

2 J. Hu, L. Zhang, X. Zhao, et al.First-line immunosuppressive therapy with rATG and CsA for severe aplastic anemia: 15 years' experience Ann Hematol, 101 (11) (2022), pp. 2405-2412

3 B.A. Patel, D.M. Townsley, P. ScheinbergImmunosuppressive therapy in severe aplastic anemia Semin Hematol, 59 (1) (2022), pp. 21-29

4 C. Chen, S.Y.M. Liu, Y. Chen, et al.Predictive value of TCR Vβ-Jβ profile for adjuvant gefitinib in EGFR mutant NSCLC from ADJUVANT-CTONG 1104 trial JCI Insight, 7 (1) (2022), Article e152631

5 C. Chen, S.M. Liu, Y. Chen, et al.Poor prognosis of intra-tumoural TRBV6-6 variants in EGFR-mutant NSCLC: results from the ADJUVANT-CTONG1104 trial Clin Transl Med, 12 (4) (2022), p. e775

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools